FDA whistleblowers accuse agency of secretly reviewing email

A group of scientists and doctors claim that FDA officials secretly monitored their email after they blew the whistle on the approval of risky medical devices. In a lawsuit, the group of 6 says the officials used the email to harass or dismiss them. And despite being warned not to expect to keep anything on their government computers under lock and key, the group claims that the FDA violated their right to privacy by reviewing personal email. Story

Suggested Articles

German researchers uncovered 28 antibodies that neutralize COVID-19 and are working with Boehringer Ingelheim to advance them into clinical testing.

Oragenics is ending a phase 2 study of its oral mucositis drug, yanking its IND application and switching its focus to a COVID-19 vaccine.

The vehicle, which Blackstone claims is the largest life sciences private fund, has committed close to $1 billion to companies including Alnylam.